Evidence map›Paper›PMID 31915139›Full record

ArticleJournal of lipid research2020

Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Ailing Ji, Xuebing Wang, Victoria P Noffsinger, Drew Jennings, Maria C de Beer, Frederick C de Beer, Lisa R Tannock, Nancy R Webb

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ailing JiSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY.
Xuebing WangSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY.
Victoria P NoffsingerSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY.
Drew JenningsDepartments of Agricultural and Medical Biotechnology,University of Kentucky, Lexington, KY.
Maria C de BeerSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY; Physiology, University of Kentucky, Lexington, KY.
Frederick C de BeerSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY; Internal Medicine,University of Kentucky, Lexington, KY.
Lisa R TannockSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY; Internal Medicine,University of Kentucky, Lexington, KY.
Nancy R WebbSaha Cardiovascular Research Center,University of Kentucky, Lexington, KY; Pharmacology and Nutritional Sciences,University of Kentucky, Lexington, KY.
University of Kentucky · US

Funding

Serum Amyloid A, Inflammasome Activation, and Abdominal Aortic AneurysmsR01HL134731 · NHLBI · UNIVERSITY OF KENTUCKY · PI DE BEER, FREDERICK C., WEBB, NANCY R · 2017 to 2020
$2.1M
HDL Remodeling in Metabolic SyndromeI01CX000773 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI WEBB, NANCY R · 2014 to 2017
–
The association of SAA with apoB lipoproteins affects cardiovascular riskI01CX000975 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI TANNOCK, LISA R · 2014 to 2017
–
CSRD VA I01 CX000773CSRD VA I01 CX000975NHLBI NIH HHS R01 HL134731
6 · The paper itself

Abstract

Liver-derived serum amyloid A (SAA) is present in plasma where it is mainly associated with HDL and from which it is cleared more rapidly than are the other major HDL-associated apolipoproteins. Although evidence suggests that lipid-free and HDL-associated forms of SAA have different activities, the pathways by which SAA associates and disassociates with HDL are poorly understood. In this study, we investigated SAA lipidation by hepatocytes and how this lipidation relates to the formation of nascent HDL particles. We also examined hepatocyte-mediated clearance of lipid-free and HDL-associated SAA. We prepared hepatocytes from mice injected with lipopolysaccharide or an SAA-expressing adenoviral vector. Alternatively, we incubated primary hepatocytes from SAA-deficient mice with purified SAA. We analyzed conditioned media to determine the lipidation status of endogenously produced and exogenously added SAA. Examining the migration of lipidated species, we found that SAA is lipidated and forms nascent particles that are distinct from apoA-I-containing particles and that apoA-I lipidation is unaltered when SAA is overexpressed or added to the cells, indicating that SAA is not incorporated into apoA-I-containing HDL during HDL biogenesis. Like apoA-I formation, generation of SAA-containing particles was dependent on ABCA1, but not on scavenger receptor class B type I. Hepatocytes degraded significantly more SAA than apoA-I. Taken together, our results indicate that SAA's lipidation and metabolism by the liver is independent of apoA-I and that SAA is not incorporated into HDL during HDL biogenesis.

Indexed as

AnimalsApolipoprotein A-IHepatocytesLipoproteins, HDLMiceMice, Inbred C57BLMice, KnockoutSerum Amyloid A ProteinApoa1 protein, mouseApolipoprotein A-ILipoproteins, HDLSerum Amyloid A Proteinadenosine 5′-triphosphate binding cassette transporter A1hepatocyteinflammatory diseaselipidationlipid metabolismlipoproteinliver metabolismnascent high density lipoprotein

Identifiers

PMID31915139
PMCPMC7053844
OpenAlexW3000417379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.